Luye Pharma Group Ltd. (HKG:2186)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.110
-0.060 (-2.76%)
Aug 27, 2026, 11:59 AM HKT

Luye Pharma Group Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
618.75471.89532.61604.81-134.39
Depreciation & Amortization
835.13783.39693.73663.46577
Other Amortization
4.367.288.127.864.99
Loss (Gain) From Sale of Assets
4.96-18.49-1.50.21-11.36
Asset Writedown & Restructuring Costs
---11.47-
Loss (Gain) From Sale of Investments
7.73-1.79-1.94-1.5514.81
Loss (Gain) on Equity Investments
31.570.77-0.79-0.83-10.27
Stock-Based Compensation
13.3721.520.6425.4549.98
Other Operating Activities
18.26136.97-53.3723.14109.71
Change in Accounts Receivable
-479.1-424.88-570.84-18.77-211.76
Change in Inventory
-44.65-84.03-54.92-26.6-134.04
Change in Accounts Payable
463.94-77.89207.24-10.9543.64
Change in Unearned Revenue
157.499.97-74.87-42.47-6.43
Change in Other Net Operating Assets
151.36-656.92891.38418.57-109.49
Operating Cash Flow
1,783167.761,5951,654182.37
Operating Cash Flow Growth
962.89%-89.48%-3.53%806.83%-82.35%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-511.4-594.07-632.66-655.68-556.2
Sale of Property, Plant & Equipment
1.787.443.175.6613.77
Divestitures
--0.02---
Sale (Purchase) of Intangibles
-491.13-1,113-532.61-507.68-985.4
Investment in Securities
-2,912536.35-511.14-675.93-2,057
Other Investing Activities
304.3162.36254.97175.32148.46
Investing Cash Flow
-3,986-1,471-1,418-1,658-3,436

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--4.9610.1-
Long-Term Debt Issued
10,03110,1198,0777,6567,155
Total Debt Issued
10,03110,1198,0827,6667,155
Short-Term Debt Repaid
---15.06--
Long-Term Debt Repaid
-10,308-8,263-8,555-8,323-7,561
Total Debt Repaid
-10,308-8,263-8,570-8,323-7,561
Net Debt Issued (Repaid)
-276.531,856-488.07-656.23-406.32
Issuance of Common Stock
--922.97-1,044
Other Financing Activities
1,0261,101406.7710.381,241
Financing Cash Flow
1,7872,956841.654.151,879

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-29.7745.41-103.6-164.15-52.37
Net Cash Flow
-445.611,698915.23-114.51-1,427

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,272-426.31962.83998.11-373.83
Free Cash Flow Growth
---3.54%--
Free Cash Flow Margin
20.16%-7.03%15.67%16.69%-7.19%
Free Cash Flow Per Share
0.33-0.110.260.29-0.11
Levered Free Cash Flow
-692.81-2,501629.06-43-778.54
Unlevered Free Cash Flow
-263.69-2,1501,051251.85-528.88

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
505.68450.1471.51369.2297.12
Cash Income Tax Paid
191.41206.93132.2392.77270.74
Change in Working Capital
249.03-1,234397.99319.79-418.08